Clinical trials: Tourette Syndrome in Children

Neurodevelopmental Disorders, Autism

Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders

• Recruiting
• Age: 8 to 17 years
• Phase 2

There are currently no approved medications for the treatment of anxiety in children and youth with neurodevelopmental disorders (NDDs), both common and rare.

Conditions

Neurodevelopmental Disorders, Autism, Autism Spectrum Disorder, Fragile X Syndrome

Trial name

CALM (NCT06081348)

Testing

Sertraline

Where

7 sites in Canada

Volunteers

130 people

Sponsor

Holland Bloorview Kids Rehabilitation Hospital